Home/Gateway Biotechnology/Philip Perez, MD
PP

Philip Perez, MD

CMO & Co-Founder

Gateway Biotechnology

Gateway Biotechnology Pipeline

DrugIndicationPhase
GW-TT1Noise-induced & Age-related Hearing Loss PreventionPre-clinical
GW-TT2Recent-onset Tinnitus; Hearing Loss in SSNHL & Ménière's diseasePhase 1
GW-TT3Severe Debilitating TinnitusPre-clinical
GW-TT5Severe Chronic TinnitusDiscovery